Ovarian cancer trials in Sweden

In Sweden 13 Also abroad 795

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Where
Linkoping, Solna
Age
18 years and over
People
900 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07318558 · EU 2023-508047-40-00
Phase 3Taking people
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Where
Lund, Solna, Uppsala
Age
18 years and over
People
582 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00
Phase 1/2Taking people
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Where
Lund, Stockholm
Age
18 years to 130 years
People
695 worldwide
Run by
AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00
No phaseTaking people
Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer
Where
Gothenburg, Linköping, Lund, Stockholm
Age
18 years and over
People
475
Run by
Sahar Salehi
See details and how to joinNCT06298877
Phase 1/2Taking people
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Where
Gothenburg, Lund, Stockholm
Age
18 years and over
People
250 worldwide
Run by
BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Lund, Solna
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 3Taking people
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Where
Linkoping, Lund, Solna, Umea, Uppsala
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00
Phase 2/3Taking people
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
Where
Solna
Age
18 years and over
People
175 worldwide
Run by
GE Healthcare
See details and how to joinNCT07219238 · EU 2024-519384-18-00
Phase 2Taking people
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
Where
Eksjo, Goteborg, Jonkoping, Linkoping, Umea, Varnamo, Vastervik
Age
18 years and over
People
40
Run by
University Hospital, Linkoeping
See details and how to joinNCT05284552 · EU 2024-515450-24-00
No phaseTaking people
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Where
Stockholm
Age
25 years to 50 years
People
3,000 worldwide
Run by
University Medical Center Nijmegen
See details and how to joinNCT04294927
No phaseNot yet taking people in Sweden
Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention
Where
Umeå
Age
20 years to 65 years
People
2,100
Run by
Umeå University
See details and how to joinNCT07423143
No phaseTaking people
Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
Where
Umeå
Age
18 years and over
People
120
Run by
Region Västerbotten
See details and how to joinNCT05855941
Phase 1Taking people
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Where
Stockholm
Age
19 years and over
People
410
Run by
Karolinska University Hospital
See details and how to joinNCT05172310